Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayashree Ramu

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
JAMA Ophthalmology|August 30, 2019
Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical TrialPhilip Hykin, A Toby Prevost, Joana C Vasconcelos, et al.
BMJ Open|September 16, 2015
Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trialSobha Sivaprasad, A Toby Prevost, James Bainbridge, et al.
BMJ Open|December 14, 2020
Protocol on a multicentre statistical and economic modelling study of risk-based stratified and personalised screening for diabetes and its complications in India (SMART India)Sobha Sivaprasad, Rajiv Raman, Ramachandran Rajalakshmi, et al.
Health Technology Assessment (Winchester, England)|June 16, 2021
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCTPhilip Hykin, A Toby Prevost, Sobha Sivaprasad, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
JAMA Ophthalmology|August 30, 2019
Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical TrialPhilip Hykin, A Toby Prevost, Joana C Vasconcelos, et al.
BMJ Open|September 16, 2015
Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trialSobha Sivaprasad, A Toby Prevost, James Bainbridge, et al.
BMJ Open|December 14, 2020
Protocol on a multicentre statistical and economic modelling study of risk-based stratified and personalised screening for diabetes and its complications in India (SMART India)Sobha Sivaprasad, Rajiv Raman, Ramachandran Rajalakshmi, et al.
Health Technology Assessment (Winchester, England)|June 16, 2021
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCTPhilip Hykin, A Toby Prevost, Sobha Sivaprasad, et al.
Pageof 2